Addressing Barriers to Hepatitis C Virus (HCV) Elimination: Real-World Outcomes in Historically Underserved Patients With Chronic HCV Infection Treated With Glecaprevir/Pibrentasvir

Press/Media

Period13 Nov 2019

Media coverage

2

Media coverage

  • TitleAddressing Barriers to Hepatitis C Virus (HCV) Elimination: Real-World Outcomes in Historically Underserved Patients With Chronic HCV Infection Treated With Glecaprevir/Pibrentasvir
    Media name/outletNational AIDS Treatment Advocacy Project
    Country/TerritoryUnited States
    Date13/11/19
    URLwww.natap.org/2019/AASLD/AASLD_10.htm
    PersonsNorbert Brau,
  • TitleFrom Clinical Trials to Real-World Evidence: Similar Virologic Cure Rates and Safety Outcomes Following Treatment With Glecaprevir/Pibrentasvir Among Patients With Chronic Hepatitis C Virus Infection and Recent Drug Use
    Media name/outletNational AIDS Treatment Advocacy Project
    Country/TerritoryUnited States
    Date13/11/19
    URLwww.natap.org/2019/AASLD/AASLD_09.htm
    PersonsNorbert Brau,